ライフサイエンスコーパス: be treated for @3 with

1 morphine on these receptor activities, rats were treated for 7 days with 0.11 mg/kg/day i.t. morphin

2 slet allografts under the kidney capsule and were treated for 7 days with 0.3, 1.0, or 3.0 mg/kg KRP2

3 Young Sprague-Dawley rats were treated for 4 days with 1) saline, 2) 7-nitroindazo

4 Two months later, they were treated for two months with: 1) vehicle; 2) AT(1)-a

5 B10.BR (H-2k) donor mice were treated for 10 days with 10 microg of FL per day.

6 When 8-week-old alpha-Gal A(-) males were treated for 8 weeks with 10 mg/kg twice daily, rena

7 BALB/c mice were treated for 9 days with 10 microg of recombinant (r

8 Alcoholic subjects were treated for 16 weeks with 100 mg of naltrexone hydr

9 Cells were treated for 24 hours with 1000 microM, 400 microM,

10 The three cultures were treated for 5 days with 18.5 kBq/ml [125I]IUdR.

11 erial urine samples from 21 patients who had been treated for bladder cancer with 20 polymorphic micr

12 nother study of 57 GERD subjects, 26 of whom were treated for 8 days with 20 mg omeprazole or 20 mg r

13 vere exacerbations in the previous 12 months were treated for 3 months with 200 mg of voriconazole tw

14 Patients were treated for 12 weeks, with 24 weeks of follow-up af

15 VMC were treated for 12 96 h with 3 100 pg/ml E2 (10 365 pM)

16 uce microglia accumulation at lesions, cords were treated for 3.5 hours with 3 mM ATP or 2 mM N(omega

17 Twenty-six eyes were treated for 30 minutes with 3 mW/cm(2) according to

18 lation on GSTP1 mRNA expression, Hep3B cells were treated for 72 h with 5-aza-dC and then subjected t

19 Inbred miniature swine that are treated for 12 d with a high dose of cyclosporin A d

20 was analysed for 124 HIV-1-infected patients being treated for the first time with a protease inhibit

21 he appearance of any cutaneous lesions, mice were treated for 15 weeks with a topical antioxidant, wi

22 duced glomerular ACE2 expression, db/db mice were treated for 16 wk with a specific ACE2 inhibitor (M

23 High-fat-fed male C57BL/6 mice were treated for 4 wk with a 2'-O-methoxyethyl chimeric

24 Cultured cells were treated for 60 seconds with a phacoemulsification u

25 The ob/ob mice were treated for 7 weeks with a specific inhibitor of gl

26 Two months after MI, rats were treated for 2 mo with: (a) vehicle; (b) the ACEi ra

27 re newborn with neurocutaneous HSV infection was treated for 21 days with acyclovir.

28 Animals were treated for four days with amphetamine (A; 5 mg/kg)

29 m consideration for stem cell transplant and was treated for 6 weeks with amphotericin B (AmB), follo

30 Patient no. 1 was treated for 30 months with an increase in HbF to 30%

31 The patient was treated for chronic lymphocytic leukemia with an unf

32 Mice were treated for 5 weeks with an anti-murine VEGF-A mono

33 Human cord blood-derived mast cells were treated for 2 weeks with anti-IgE.

34 All 9 patients (100%) in the control group were treated for cellulitis with antibiotics vs 2 patien

35 y linked with the reduction in I(Ca,L), dogs were treated for 48 h with buthionine sulfoximine, an in

36 After 6 weeks of diabetes, rats were treated for 2 weeks with C-peptide to restore circu

37 Mice are treated for 5 days with cefoperazone in the drinking

38 plasma compartment for the STD subjects who were treated for urethritis, with changes being noted in

39 WT and SOCS3 knockdown C57BL6 mice were treated for 5 days with citrate buffer or 0.1 mg/kg

40 1202 participants (5.9%; 95% CI, 4.6%-7.2%) were treated for recurrence with curative intent, with l

41 Apoe(-/-) mice were treated for 11 weeks with daily injections of Cl-am

42 lity rates for both children and adolescents being treated for ESKD with dialysis decreased significa

43 At the onset of clinical arthritis, mice were treated for 4 weeks with different treatments, incl

44 A group of patients with early RA was treated for 6 months orally with dnaJP1, a peptide t

45 -like pathology (6, 9, and 15 months of age) were treated for 3 months with doses of memantine equiva

46 ts induced by carbon tetrachloride (CCl(4) ) were treated for 5 days with droxidopa (15 mg/kg, twice

47 diatric (nonneonatal) and adult patients who were treated for varicella pneumonia with ECLS at the Un

48 chotic primary major depressive disorder and were treated for 16 weeks with either cognitive behavior

49 om injection of A549 human lung cancer cells were treated for 28 days with either i.v. saline or Ang-

50 ng remyelination after MHV-A59 demyelination were treated for 3 d with either exogenous FGF2 or an FG

51 Brain-dead Fisher rats were treated for 6 hours with either saline or saline pl

52 The ZDF rats were treated for 6 weeks with either bezafibrate, a lipi

53 Both WT and AT(2) receptor knockout mice were treated for 7 days with either ACE inhibitors or AR

54 atients (8%) with indeterminate final result were treated for thromboembolic disease with either anti

55 in streptozotocin-induced diabetic rats that were treated for 12 weeks with enalapril, an ACE inhibit

56 ly; P>.05) whether or not the recipients had been treated for 6 weeks with estradiol.

57 , harvested at standard commercial maturity, were treated for 36 h with ethylene (ET, 1000 ppm) or ai

58 < or =48 hours) of clinically diagnosed gout were treated for 8 days with etoricoxib, 120 mg/day (n =

59 Mice were treated for 7 days with etorphine (200 microg/kg/da

60 5704 men in the clinical data repository who were treated for AGA with finasteride, 1.25 mg/d or less

61 e the anxiolytic effects of fluoxetine, rats were treated for 14 days with fluoxetine (10 mg kg(-1) d

62 Rats were treated for 36 weeks with haloperidol decanoate or

63 negative for Mycobacterium tuberculosis who were treated for tuberculosis (those with highly probabl

64 Patient no. 2 was treated for 24 months with HU before developing sple

65 The patient was treated for 4 months with imatinib mesylate.

66 diazepam, lorazepam, or alprazolam, patients were treated for 4 weeks with imipramine, buspirone, or

67 Rats were treated for 12 d with increasing doses (10-320mg .

68 HTM cells and two transformed HTM cell lines were treated for 24 hours with increasing concentrations

69 In the first trial, patients were treated for 9 weeks with induction chemotherapy con

70 tio increased 17-fold when the diabetic rats were treated for 6 h with insulin.

71 Patients with chronic hepatitis C (n = 103) were treated for 24 weeks with interferon alfa 2b and fo

72 ion, the best response occurred in those who were treated for 48 weeks with interferon and ribavirin.

73 corresponding to 27 human gestational weeks) were treated for 14 days with intravenous (i.v.) FG-4095

74 In Phase 3, both groups were treated for 6 more months with IV rHuEPO.

75 Rats in the last week of pregnancy were treated for 5 days with L-NG-(1-Iminoethyl)lysine (

76 Patients were treated for 52 weeks with lamivudine (100 mg daily)

77 In our pooled data analysis, 634 patients were treated for 8 weeks with LDV/SOF, of whom all had o

78 NLCs, cocultures of monocytes and CLL cells were treated for 14 days with lenalidomide, which result

79 pneumoniae were isolated from 2 patients who were treated for pneumonia with levofloxacin.

80 ts/ml), were left untreated for 24 hours, or were treated for 3 hours with lipopolysaccharide (LPS; 1

81 The patient returns to clinic, having been treated for >6 months with LMWH.

82 The cultures were treated for 24 hours with medium supplemented with

83 Ligament constructs were treated for 7 days with medium supplemented with se

84 f fatal MIs in men age 65 years or older who are treated for 6 months compared with men who are not t

85 vitro studies, Caco-2 enterocyte-like cells were treated for 7 days with metformin (10 mM) and/or ro

86 HFD) or a standard chow for 6 weeks and then were treated for 7 days with metformin (250 mg/kg/day) a

87 Refeeding syndrome may occur in children who are treated for malnutrition, even with moderately low p

88 tor regulation in mRPE cells, cultured cells were treated for 24 hours with mouse TNF-alpha, human IL

89 mice bearing xenografts of human Caki-I RCC were treated for 4 weeks with MZ-4-71 injected s.c. twic

90 etrospective analysis of 32 HCV patients who were treated for SRR with OKT3 (n=15) or TG (n=17) using

91 e (1 with early onset and 1 with late onset) were treated for 3 months with oral bovine CII.

92 Nine untreated HIV-1-infected volunteers were treated for 12 weeks with peginterferon alfa-2a.

93 Mice were treated for 30 days with plasma from healthy human

94 Nine patients were treated for AHR with PP and IVIg.

95 Mice were treated for 14 days with prednisolone, mycophenolat

96 that had experienced status epilepticus and were treated for 2 months with rapamycin displayed signi

97 ed back to standard composition or when mice were treated for 1 wk with rosiglitazone, a specific ago

98 The RGCs were treated for 24 hours with rotenone or staurosporine

99 cells concentrated in S-phase or G0/G1-phase were treated for 24 h with short or long multiwalled car

100 The patients were treated for 24 weeks with sofosbuvir and ribavirin

101 Our patients, however, had been treated for a longer period with SSRIs and were mor

102 Db/db mice were treated for 5 weeks with Sulf2 ASO (20 or 50 mg/kg

103 For 1 year, we studied Ugandan children who were treated for uncomplicated malaria with sulfadoxine-

104 5G8(-/-) mice) and their littermate controls were treated for 7 days with T0901317.

105 Prior to the challenge, mice were treated for 5 days with tetracycline, erythromycin,

106 to the lateral ventricles of adult rats, who were treated for 18 d thereafter with the mitotic marker

107 GLP-1 signaling, sham-operated control rats were treated for 8 days with the GLP-1 analog liraglutid

108 Following a 90-day washout period, they were treated for 90 days with the other capsules.

109 combat missions in Iraq and Afghanistan and were treated for exposure keratopathy with the BOSP, a F

110 All patients were treated for acute respiratory failure with titrated

111 00 persons are chronically infected, CHB has been treated for centuries with traditional Chinese medi

112 to relengthen was abolished after cells had been treated for 12 minutes with trypsin (0.25 microgram

113 PBMCs-DCs were treated for 24 hours with various concentrations of

114 Hypothyroid mice were treated for 10 days with varying doses of T3 or GC-

115 Cells were treated for 1 week with vehicle, 1 nM E(2) or 100 n

116 Normotensive Wistar-Kyoto (WKY) and SHR were treated for 2 weeks with vehicle (WKY+V and SHR+V)

117 Patients were treated for 10 weeks with weekly injections and the

118 Transgenic mice were treated for 12 weeks with weekly i.p. injections of